Adriamycin therapy by continuous intravenous infusion in patients with metastatic breast cancer
โ Scribed by Sewa S. Legha; Robert S. Benjamin; Bruce Mackay; H. Y. Yap; Sidney Wallace; Michael Ewer; George R. Blumenschein; Emil J Freireich
- Publisher
- John Wiley and Sons
- Year
- 1982
- Tongue
- English
- Weight
- 459 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Data on 162 women (90 premenopausal and 72 postmenopausal) with metastatic breast cancer randomized to receive cyclophosphamide, Adriamycin (doxorubicin) and 5-fluorouracil (CAF) on two Eastern Cooperative Oncology Group (ECOG) protocols were analyzed. Twenty-three percent had complete remission; 39
thecin, have shown outstanding preclinical activity against colorectal carcinoma. Irinotecan (CPT-11), another camptothecin derivative, has demonstrated clinical
In 126 postmenopausal women with metastatic breast cancer, four chemotherapeutic combination programs were tested. Patients were stratified and randomized to one o f the four programs: (1) fluorouracil, cytoxan and prednisone (CFP): (2) fluorouracil, cytoxan and Adriamycin (CAF); (3) cytoxan and Adr